Mammography

Mammography "Sweet Spot" Recall Rate; MRI for Early-Stage Testicular Cancer Follow-Up; COVID-19 and Body Self-Attack; Plus, Global Radiology

The currently acceptable 12 percent-to-14 percent recall rate is too high to maximize cancer detection and minimize biopsies and unnecessary follow-up studies.

COVID-19 Vaccine-Related Adenopathies on Breast MRI; Baseline Mammography at 40; Cherenkov Imaging to Improve Radiation Therapy Improvement; and Sexual Harassment and Gender Discrimination in Radiology

Study shows that baseline mammography screening to identify breast density, starting at age 40, is cost-effective.

After more than two decades, women between ages 20 and 39 are seeing a slight increase in the rates of breast cancer mortality.

Here's what to expect this week on Diagnostic Imaging.

Female breast cancer diagnosis is now the most common cancer diagnosis globally, largely affecting women in transitioning countries.

When deciding whether to continue screening mammography with older breast cancer survivors, consider life expectancy, experts said.

A focus on more comprehensive, up-to-date research and inclusion of racial disparities data will lead to more appropriate mammography screening guidelines, experts say.

With more axillary adenopathies likely to present on breast imaging, Society of Breast Imaging experts offer guidance for best management during the pandemic.

What could happen if the subject of discussion is a widely used radiology exam?

Here's what to expect this week on Diagnostic Imaging.

Swollen lymph nodes visualized on mammography and ultrasound appear days post-vaccination and could be mistaken for malignancies.

Seno’s Imagio® breast imaging system can help providers distinguish, in real-time, between benign and malignant breast lesions.

Here's what to expect this week on Diagnostic Imaging.

A pilot study intervention successfully provides mammograms for patients who face screening challenges.

More women are learning about their breast density levels, but the rates still remain low.

As imaging volumes continue to rise, experts offer a targeted solution that could lead to faster throughput.

In a $64-million deal, Hologic has acquired SOMATEX Medical Technologies GmbH, effectively expanding its breast health care solutions capabilities.

Study finds basing screening recommendations on age does not maximize the benefit – using different factors to design targeted testing would be better.

Here's what to expect this week on Diagnostic Imaging.

While the pandemic raged, work continued to advance the development of AI tools with breast imaging services.

The December 2020 Diagnostic Imaging eBook.

Younger and African American patients face significantly increased odds of having their symptoms associated with radiation therapy under-treated by providers.

Here's what to expect this week on Diagnostic Imaging.